Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

297 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study.
Benatar M, Wuu J, Andersen PM, Bucelli RC, Andrews JA, Otto M, Farahany NA, Harrington EA, Chen W, Mitchell AA, Ferguson T, Chew S, Gedney L, Oakley S, Heo J, Chary S, Fanning L, Graham D, Sun P, Liu Y, Wong J, Fradette S. Benatar M, et al. Among authors: mitchell aa. Neurotherapeutics. 2022 Jul;19(4):1248-1258. doi: 10.1007/s13311-022-01237-4. Epub 2022 May 18. Neurotherapeutics. 2022. PMID: 35585374 Free PMC article. Clinical Trial.
Correction to: Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study.
Benatar M, Wuu J, Andersen PM, Bucelli RC, Andrews JA, Otto M, Farahany NA, Harrington EA, Chen W, Mitchell AA, Ferguson T, Chew S, Gedney L, Oakley S, Heo J, Chary S, Fanning L, Graham D, Sun P, Liu Y, Wong J, Fradette S. Benatar M, et al. Among authors: mitchell aa. Neurotherapeutics. 2022 Sep;19(5):1686. doi: 10.1007/s13311-022-01286-9. Neurotherapeutics. 2022. PMID: 36175782 Free PMC article. No abstract available.
ALS Identified: two-year findings from a sponsored ALS genetic testing program.
Goutman SA, Goyal NA, Payne K, Paisán-Ruiz C, Kupelian V, Kang ML, Mitchell AA, Fecteau TE. Goutman SA, et al. Among authors: mitchell aa. Ann Clin Transl Neurol. 2024 Aug;11(8):2201-2211. doi: 10.1002/acn3.52140. Epub 2024 Jul 23. Ann Clin Transl Neurol. 2024. PMID: 39044379 Free PMC article.
Patterns of Prescription Medication Use during the First Trimester of Pregnancy in the United States, 1997-2018.
Werler MM, Kerr SM, Ailes EC, Reefhuis J, Gilboa SM, Browne ML, Kelley KE, Hernandez-Diaz S, Smith-Webb RS, Garcia MH, Mitchell AA; National Birth Defects Prevention Study and Birth Defects Study To Evaluate Pregnancy exposureS. Werler MM, et al. Among authors: mitchell aa. Clin Pharmacol Ther. 2023 Oct;114(4):836-844. doi: 10.1002/cpt.2981. Epub 2023 Jul 11. Clin Pharmacol Ther. 2023. PMID: 37356083 Free PMC article.
Maternal exposure to hydroxychloroquine and birth defects.
Howley MM, Werler MM, Fisher SC, Van Zutphen AR, Carmichael SL, Broussard CS, Heinke D, Ailes EC, Pruitt SM, Reefhuis J, Mitchell AA, Browne ML; National Birth Defects Prevention Study. Howley MM, et al. Among authors: mitchell aa. Birth Defects Res. 2021 Oct 15;113(17):1245-1256. doi: 10.1002/bdr2.1943. Epub 2021 Jul 23. Birth Defects Res. 2021. PMID: 34296811 Free PMC article.
297 results